Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes

Concomitant Dry Eye in Patients With Ocular Allergy: an Under Recognized and Poorly Managed Syndrome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01679015

Enrollment

250

Registered

2012-09-05

Start date

2012-08-31

Completion date

2014-02-28

Last updated

2016-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Conjunctivitis, Dry Eyes

Keywords

Burning, Dryness, Itching, Blurry Vision

Brief summary

Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ability to give informed consent * Males and females at least 18 years of age * Personal history of allergic disorders including but not limited to allergic conjunctivitis, allergic rhinitis, contact dermatitis and other eczema, and asthma * Diagnosis of allergic conjunctivitis * Presence of any of the following signs including conjunctival redness and papillae, chemosis, red edematous eyelids, reduced tear clearance, reduced TBUT, vital staining, stringy discharge, and/or symptoms including ocular itching, burning and tearing, runny nose or itchy throat

Exclusion criteria

* Active ocular or systemic infection * History of ocular infection within past 6 months * Presence of punctal plugs * Recent ocular surgery within past 6 months * Current use of chemotherapeutic agents * Presence of ocular trauma * Inability to give informed consent * Women who are pregnant, nursing or lactating

Design outcomes

Primary

Measure	Time frame
Prevalence of dry eye in an allergic population presenting to a high volume optometry practice	up to 2 years

Secondary

Measure	Time frame
Prevalence of allergic patients with moderate to severe ocular signs and symptoms	up to 2 years

Countries

United States

Outcome results